OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Huntington's disease: a clinical review
Peter McColgan, Sarah J. Tabrizi
European Journal of Neurology (2017) Vol. 25, Iss. 1, pp. 24-34
Open Access | Times Cited: 900

Showing 1-25 of 900 citing articles:

The Microbiota-Gut-Brain Axis
John F. Cryan, Kenneth J. O’Riordan, Caitlin S.M. Cowan, et al.
Physiological Reviews (2019) Vol. 99, Iss. 4, pp. 1877-2013
Open Access | Times Cited: 3429

Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
Theodore S. Kapellos, Lorenzo Bonaguro, Ioanna D. Gemünd, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 693

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Na Xie, Lu Zhang, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 653

Structural variant calling: the long and the short of it
Medhat Mahmoud, Nastassia Gobet, Diana Ivette Cruz-Dávalos, et al.
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 557

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Sarah J. Tabrizi, Michael Flower, Christopher A. Ross, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 10, pp. 529-546
Open Access | Times Cited: 393

The Application of Ferroptosis in Diseases
Yangmin Qiu, Yue Cao, Wangjia Cao, et al.
Pharmacological Research (2020) Vol. 159, pp. 104919-104919
Closed Access | Times Cited: 333

The Role of Mitochondria in Reactive Oxygen Species Generation and Its Implications for Neurodegenerative Diseases
Saima Kausar, Feng Wang, Hongjuan Cui
Cells (2018) Vol. 7, Iss. 12, pp. 274-274
Open Access | Times Cited: 279

Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications
Valeria Gasperi, Matteo Sibilano, Isabella Savini, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 974-974
Open Access | Times Cited: 219

Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
Qian Cai, Yu Young Jeong
Cells (2020) Vol. 9, Iss. 1, pp. 150-150
Open Access | Times Cited: 205

Single-nucleus RNA-seq identifies Huntington disease astrocyte states
Osama Al‐Dalahmah, Alexander A. Sosunov, Ayesha Shaik, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 204

Chemoenzymatic Semisynthesis of Proteins
Robert E. Thompson, Tom W. Muir
Chemical Reviews (2019) Vol. 120, Iss. 6, pp. 3051-3126
Open Access | Times Cited: 202

Lipid Droplets in Neurodegenerative Disorders
Brandon C. Farmer, Adeline E. Walsh, Jude C. Kluemper, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 198

Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases
Julia Konovalova, Dmytro Gerasymchuk, Ilmari Parkkinen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6055-6055
Open Access | Times Cited: 175

Neurovascular Unit Dysfunction and Neurodegenerative Disorders
Xing Yu, Caihong Ji, Anwen Shao
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 174

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
Sandra Franco-Iborra, Miquel Vila, Céline Perier
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 172

Mitophagy in Human Diseases
Laura Doblado, Claudia Lueck, Claudia Rey, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3903-3903
Open Access | Times Cited: 168

Fluorescent Diagnostic Probes in Neurodegenerative Diseases
Jin Zhou, Paramesh Jangili, Subin Son, et al.
Advanced Materials (2020) Vol. 32, Iss. 51
Closed Access | Times Cited: 165

Glucose, glycolysis, and neurodegenerative diseases
Bor Luen Tang
Journal of Cellular Physiology (2020) Vol. 235, Iss. 11, pp. 7653-7662
Closed Access | Times Cited: 156

Therapeutic Advances for Huntington’s Disease
Ashok Kumar, Vijay Kumar, Kritanjali Singh, et al.
Brain Sciences (2020) Vol. 10, Iss. 1, pp. 43-43
Open Access | Times Cited: 142

An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics
Sanjog R. Chintalaphani, Sandy S. Pineda, Ira W. Deveson, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 126

Neurogenesis in aging and age-related neurodegenerative diseases
Luka Čulig, Xixia Chu, Vilhelm A. Bohr
Ageing Research Reviews (2022) Vol. 78, pp. 101636-101636
Open Access | Times Cited: 117

Apoptosis and its therapeutic implications in neurodegenerative diseases
Nour S. Erekat
Clinical Anatomy (2021) Vol. 35, Iss. 1, pp. 65-78
Closed Access | Times Cited: 115

The molecular and cellular basis of copper dysregulation and its relationship with human pathologies
May T. Maung, Alyssa Carlson, Monserrat Olea‐Flores, et al.
The FASEB Journal (2021) Vol. 35, Iss. 9
Open Access | Times Cited: 104

Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward
Sara Arciniegas Ruiz, Hagit Eldar-Finkelman
Frontiers in Molecular Neuroscience (2022) Vol. 14
Open Access | Times Cited: 84

Current and Possible Future Therapeutic Options for Huntington’s Disease
Mackenzie Wendy Ferguson, Connor J. Kennedy, Thulani H. Palpagama, et al.
Journal of Central Nervous System Disease (2022) Vol. 14
Open Access | Times Cited: 80

Page 1 - Next Page

Scroll to top